These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35855640)

  • 1. Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.
    Jiang XY; Guan FF; Ma JX; Dong W; Qi XL; Zhang X; Chen W; Gao S; Gao X; Pan S; Wang JZ; Ma YW; Zhang LF; Lu D
    Dis Model Mech; 2023 May; 16(5):. PubMed ID: 35855640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
    Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
    J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
    Sun TL; Li WQ; Tong XL; Liu XY; Zhou WH
    Eur J Pharmacol; 2021 Jan; 891():173690. PubMed ID: 33127362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway.
    Ma H; Ge Y; Di C; Wang X; Qin B; Wang A; Hu W; Lai Z; Xiong X; Qi R
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATGL deficiency aggravates pressure overload-triggered myocardial hypertrophic remodeling associated with the proteasome-PTEN-mTOR-autophagy pathway.
    Han X; Zhang YL; Lin QY; Li HH; Guo SB
    Cell Biol Toxicol; 2023 Oct; 39(5):2113-2131. PubMed ID: 35218467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation.
    Cattin ME; Wang J; Weldrick JJ; Roeske CL; Mak E; Thorn SL; DaSilva JN; Wang Y; Lusis AJ; Burgon PG
    J Biol Chem; 2015 Oct; 290(44):26699-714. PubMed ID: 26359501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
    Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
    Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
    Shi JY; Chen C; Xu X; Lu Q
    Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
    Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
    J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crude terpene glycoside component from Radix paeoniae rubra protects against isoproterenol-induced myocardial ischemic injury via activation of the PI3K/AKT/mTOR signaling pathway.
    Ke Z; Wang G; Yang L; Qiu H; Wu H; Du M; Chen J; Song J; Jia X; Feng L
    J Ethnopharmacol; 2017 Jul; 206():160-169. PubMed ID: 28549860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats.
    Savergnini SQ; Ianzer D; Carvalho MB; Ferreira AJ; Silva GA; Marques FD; Peluso AA; Beiman M; Cojocaru G; Cohen Y; Almeida AP; Rotman G; Santos RA
    PLoS One; 2013; 8(3):e57757. PubMed ID: 23469229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF15 protects against isoproterenol-induced cardiac hypertrophy via regulation of cell death and inhibition of Akt/mTOR signaling.
    Gao L; Guo Y; Liu X; Shang D; Du Y
    Biochem Biophys Res Commun; 2017 May; 487(1):22-27. PubMed ID: 28336438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuating PI3K/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells.
    Magaye RR; Savira F; Hua Y; Xiong X; Huang L; Reid C; Flynn BL; Kaye D; Liew D; Wang BH
    Int J Biochem Cell Biol; 2021 May; 134():105952. PubMed ID: 33609744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways.
    Chen Y; Liu Z; Hu Z; Feng X; Zuo L
    Bioengineered; 2022 Apr; 13(4):8323-8333. PubMed ID: 35311628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling.
    Jia P; Wu N; Yang H; Guo Y; Guo X; Sun Y
    Transl Res; 2021 Jul; 233():47-61. PubMed ID: 33578031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
    Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
    J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
    Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
    Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
    Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
    Wu Y; Wang BX; Guo YY; Wang YQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):284-8. PubMed ID: 26387199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.